Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.82% | 5.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.82% | 5.40% | |||
| Cost of Revenue | -3.70% | 4.17% | |||
| Gross Profit | 3.64% | 6.18% | |||
| SG&A Expenses | -4.21% | 7.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.42% | 6.51% | |||
| Operating Income | 12.76% | -8.32% | |||
| Income Before Tax | 13.98% | -2.38% | |||
| Income Tax Expenses | -59.50% | 2,286.67% | |||
| Earnings from Continuing Operations | 14.28% | -3.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.28% | -3.02% | |||
| EBIT | 12.76% | -8.32% | |||
| EBITDA | 13.72% | -9.29% | |||
| EPS Basic | 14.36% | -2.43% | |||
| Normalized Basic EPS | 21.58% | -6.64% | |||
| EPS Diluted | 14.36% | -2.43% | |||
| Normalized Diluted EPS | 21.58% | -6.64% | |||
| Average Basic Shares Outstanding | 0.09% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||